Recent Posts
Big losses and bigger wins of 2024
December 2024 by Robbie Paul posted in Funds, Startups, CEO, Technology, Growth
Designed by Apple in California
October 2024 by Robbie Paul posted in Funds, Startups, CEO, Technology, Growth
I'm excited to share that Pie Funds has invested $10m into Growth Fund II, bringing us to $98m of our $100m target. Their investment supports my case that the next Apple should be built from New Zealand. That may sound far-fetched so here are the reasons why it is possible.
Reflections on Tradify and the Venture Ecosystem
October 2024 by Robbie Paul posted in Startups, CEO, Growth, Community
Read the 7 reflections from Icehouse Ventures CEO Robbie Paul, following Tradify's impending acquisition by Access Group.
10 Key Takeaways from our Growth Fund I Annual Report
September 2024 by Robbie Paul posted in Startups, CEO, Growth, Community
Read the 10 key takeaways from Icehouse Ventures CEO Robbie Paul, following the release of our Growth Fund I Annual Report.
Allbirds founder and former All White, Tim Brown, has joined Icehouse Ventures. Read Icehouse Ventures CEO, Robbie Paul's perspectives that informed Tim's appointment.
2023 Top Three...
December 2023 by Robbie Paul posted in Startups, CEO, Growth, Community
Losses, Lowlights, Wins, and Highlights
I noted there was a potential “backlog” of losses to come at our Singapore Limited Partner dinner in July. We had averaged more than five per year between 2017 and 2021. Despite a growing and maturing portfolio (215 new companies since 2017), “only” three companies had failed in the 18 months from the start of 2022.
The LPs were unfazed. They understood that many startups fail. I also laid out the factors leading to the relative dearth in recent losses: strong capital raises in 2021, round extensions and burn reductions in 2022, and convertible notes and down rounds in early 2023.
The LPs knew that venture capital was defined by backing winners, not avoiding losses. They were buoyed by the strong growth of many Kiwi companies. The aggregate revenue of the companies in Growth Fund I has scaled from $153m in 2021 to $254 in 2022 to $384m today. This includes remarkable execution by the likes of Halter, Hnry, Crimson, and Tracksuit.
Then Supie happened, prompting more than 50 articles by the press and ample negatively directed at startups (a lowlight). This was followed by an outpouring of support from seasoned entrepreneurs and investors for the Supie team and mission (a highlight).
Below are a few more highlights and lowlights and check out our 2023 NZ Startup Year in Review here.
Also, a final reminder of our year-end deadline for Growth Fund II.
This is our flagship Series A-D stage fund that will invest in 20 Kiwi tech companies over the next three years. It builds upon our first fund which invested in greats like those named above as well as Mint Innovation, Open Star, Sharesies, LawVu, Dawn Aerospace, and others.
We have >$75m committed including Generate Kiwisaver, Sir Stephen Tindall, an Iwi, and nearly 400 Kiwis and family offices. Interested? Learn more and review the Application here.
Here’s to an amazing year for NZ venture in 2024.
Thanks
Robbie
2023 Top Three…
Highlights
- Generate KiwiSaver supporting Icehouse Ventures Growth Fund II and Movac Fund VI. They join Simplicity and Fisher Funds who are increasingly participating in the space. Even if their investment grew proportionate to their FUM growth this could result in hundreds of millions being invested in Kiwi startups in the coming decade.
- Founders becoming shareholders in Icehouse Ventures. The best part of our $10m equity raise was having dozens of founders buying into our company and our long-term mission. A huge thanks to Anne Fulton, Jamie Beaton, Milot Zeqiri and Brittany Gribben, Shaun Quincey, Guy Horrocks, Scott McPhee, Mike Carden, Sean Molloy, Brooke Roberts, and many others.
- The rise and rise of second-time founders. A sign of a vibrant ecosystem is the recycling of talent, experience, and capital. We were excited to invest in more second-time founders in the past 12 months than in our first 12 years. This includes Shaun Quincey (Simfuni), Mark Hurley (Caruso), Greg O'Grady (Alimetry), Lisa King (AF), and Derek Handley (Aera).
Lowlights
- Theresa Gattung’s spotlight on the $32b gender investment gap. The report served as yet another reminder of the very small portion of venture capital that is being invested in women entrepreneurs.
- Toxic responses to our use of Aotearoa in ads. Promotions of our Growth Fund and “companies revolutionizing the world from Aotearoa New Zealand” on Facebook were consistently peppered with offensive comments.
- Showcase company allocations scaled back. Though this is a sign of a healthy ecosystem.
Losses
- Supie’s failure. See my Op-Ed here.
- Two other software startups failed but were not announced/ picked up by the media.
- Significant down rounds by three others. The good news is they are funded to continue to pursue their mission.
Wins
- Halter’s $85m capital raise defying the venture capital drought. Read more.
- The rise and rise of Hnry and their $35m capital raise. Read more.
- Jamie Beaton’s recognition as EY Young Entrepreneur of the Year. Read more.
Check out the 2023 NZ Startup Year in Review
The end of the beginning for Icehouse Ventures
November 2023 by Robbie Paul posted in Startups, CEO, Growth, Community
Our $10m capital raise
Government can thank startups for BlackRock’s $2 billion clean energy investment
August 2023 by Robbie Paul posted in Funds, Startups, Founders, CEO, Portfolio, Technology
Our thoughts on how Blackrock's $2 billion clean energy fund came to our shores
IVX: New VC fund investing in NZ's most promising startups
July 2021 by Robbie Paul posted in Funds
Introducing the IVX Fund
Today we announced the launch of IVX (as in Icehouse Ventures Expansion), a late-stage venture fund that will invest in 20-30 of NZ’s leading tech companies.
We have already raised over $50m to date from Simplicity, an Iwi, Hobson Wealth, Sir Stephen Tindall, and over 100 individual investors and are moving towards a $75m final close. The fund is now open for investment from new investors.
What is "late-stage venture capital?
IVX is a late-stage fund. What does that mean? Most of the capital will be deployed into companies with established and growing teams, well-developed products & services, evidence of competitive wins, five or more years in market, revenue & proven business models, and strong governance. And the most critical feature: potential for significant global growth. Example companies already in the IVX portfolio include Shuttlerock who are generating $10m+ revenue, Dawn Aerospace who have their technology commercially operating on multiple satellites in space, and Sir John Kirwan's Mentemia whose tech is used by The Warehouse, Sky, Eroad, and others.
How does IVX compare to other VC funds?
IVX leverages our unique relationships, information, and follow-on rights we have as a result of being among New Zealand’s most active early-stage investors. Our pipeline includes our 250+ startup investments, a subset of which thrive and become sought after. This simply cannot be reverse engineered. (Note IVX can also invest in startups outside of our family.)
This is not a novel model. YCombinator, a Silicon Valley-based accelerator that got its start making $20k pre-seed investments, subsequently raised a $1b “continuity” fund to invest further in its top performers like Airbnb and Dropbox. Having long-duration relationships with founders and longitudinal data on their performance is a real advantage.
The first startup we invested in has been acquired - exciting news for Biomatters
April 2019 by Robbie Paul posted in Portfolio
Biomatters was among the first startups to present to the Ice Angels investment network after it was formed by its five founding members in December 2003. The Ice Angels and a handful of others provided seed funding in 2004, and we’ve invested multiple times in the company as they evolved and grew over the years. One of the members has remained a Board member since day one.
The founders of Biomatters set out with a vision of “uncorking bottlenecks in the disease-research and drug-discovery processes.” This absolutely aligned to our desire to back ambitious startups that could add significantly to the future of New Zealand.
Their tenacity, commitment, and world-leading team has flown under the radar for more than a decade. The acquisition offers Biomatters the firepower they deserve to help them shine on the global stage. It is an exciting next step for the company and the team as they join forces to create a life sciences software platform with technology and data analysis at the core of scientific research around the world.
It is also good news for New Zealand’s fast-growing entrepreneurial sector. As we have seen with other investor returns of this magnitude, the capital, confidence, and expertise is often recycled into the startup ecosystem. Good ideas breed other good ideas; company founders breed founders; confidence breeds confidence, and capital breeds capital. It is very virtuous.
Ice Angels invests in startups knowing their journeys are risky and can be long. It’s fantastic to have the risk and patience rewarded in this case.
As we power up the new company next week, Icehouse Ventures (which includes Ice Angels), with our first official day being 1 May, we look forward to meeting more entrepreneurs with the potential to make their mark on the world stage like the Biomatters team.
Congratulations to Brett and the Biomatters team. Thanks for your hard work and contribution to the future of New Zealand.
- Robbie Paul
CEO of Icehouse Ventures